BAUSCH HEALTH COS INC (BHC.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:BHC • CA0717341071

7.77 CAD
0 (0%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

4

BHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Pharmaceuticals industry. BHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BHC has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BHC was profitable.
  • BHC had a positive operating cash flow in the past year.
  • In the past 5 years BHC always reported negative net income.
  • BHC had a positive operating cash flow in 4 of the past 5 years.
BHC.CA Yearly Net Income VS EBIT VS OCF VS FCFBHC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.35%, BHC is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • BHC's Return On Invested Capital of 6.78% is amongst the best of the industry. BHC outperforms 84.85% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BHC is below the industry average of 8.73%.
  • The 3 year average ROIC (5.45%) for BHC is below the current ROIC(6.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROIC 6.78%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.45%
ROIC(5y)4.93%
BHC.CA Yearly ROA, ROE, ROICBHC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.61%, BHC is in the better half of the industry, outperforming 75.76% of the companies in the same industry.
  • BHC has a better Operating Margin (20.68%) than 84.85% of its industry peers.
  • In the last couple of years the Operating Margin of BHC has grown nicely.
  • BHC has a Gross Margin of 70.67%. This is amongst the best in the industry. BHC outperforms 90.91% of its industry peers.
  • BHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
BHC.CA Yearly Profit, Operating, Gross MarginsBHC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BHC is creating some value.
  • BHC has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BHC has been increased compared to 5 years ago.
  • Compared to 1 year ago, BHC has an improved debt to assets ratio.
BHC.CA Yearly Shares OutstandingBHC.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BHC.CA Yearly Total Debt VS Total AssetsBHC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • Based on the Altman-Z score of 0.24, we must say that BHC is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BHC (0.24) is better than 63.64% of its industry peers.
  • BHC has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as BHC would need 19.41 years to pay back of all of its debts.
  • BHC has a better Debt to FCF ratio (19.41) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Altman-Z 0.24
ROIC/WACC1.03
WACC6.58%
BHC.CA Yearly LT Debt VS Equity VS FCFBHC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • BHC has a Current Ratio of 1.30. This is a normal value and indicates that BHC is financially healthy and should not expect problems in meeting its short term obligations.
  • BHC has a Current ratio of 1.30. This is in the lower half of the industry: BHC underperforms 69.70% of its industry peers.
  • BHC has a Quick Ratio of 1.30. This is a bad value and indicates that BHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of BHC (0.97) is worse than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.97
BHC.CA Yearly Current Assets VS Current LiabilitesBHC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.33% over the past year.
  • BHC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.91% yearly.
  • Looking at the last year, BHC shows a small growth in Revenue. The Revenue has grown by 5.86% in the last year.
  • The Revenue has been growing slightly by 2.28% on average over the past years.
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%

3.2 Future

  • Based on estimates for the next years, BHC will show a decrease in Earnings Per Share. The EPS will decrease by -3.58% on average per year.
  • BHC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.40% yearly.
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BHC.CA Yearly Revenue VS EstimatesBHC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC.CA Yearly EPS VS EstimatesBHC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 1.49 indicates a rather cheap valuation of BHC.
  • Compared to the rest of the industry, the Price/Earnings ratio of BHC indicates a rather cheap valuation: BHC is cheaper than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, BHC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 1.33, the valuation of BHC can be described as very cheap.
  • BHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. BHC is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, BHC is valued rather cheaply.
Industry RankSector Rank
PE 1.49
Fwd PE 1.33
BHC.CA Price Earnings VS Forward Price EarningsBHC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BHC indicates a rather cheap valuation: BHC is cheaper than 81.82% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BHC indicates a rather cheap valuation: BHC is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.95
EV/EBITDA 6.62
BHC.CA Per share dataBHC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40 -60

4.3 Compensation for Growth

  • BHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y-1.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAUSCH HEALTH COS INC

TSX:BHC (2/4/2026, 7:00:00 PM)

7.77

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-29
Earnings (Next)02-18
Inst Owners45.78%
Inst Owner ChangeN/A
Ins Owners10.79%
Ins Owner ChangeN/A
Market Cap2.88B
Revenue(TTM)10.03B
Net Income(TTM)362.00M
Analysts48.89
Price Target10.2 (31.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.24%
Min EPS beat(2)-7.07%
Max EPS beat(2)2.59%
EPS beat(4)1
Avg EPS beat(4)-8.49%
Min EPS beat(4)-25.13%
Max EPS beat(4)2.59%
EPS beat(8)4
Avg EPS beat(8)-3.92%
EPS beat(12)7
Avg EPS beat(12)-2.32%
EPS beat(16)8
Avg EPS beat(16)-5.93%
Revenue beat(2)2
Avg Revenue beat(2)0.5%
Min Revenue beat(2)0.36%
Max Revenue beat(2)0.64%
Revenue beat(4)3
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-1.57%
Max Revenue beat(4)0.64%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)9
Avg Revenue beat(12)1.1%
Revenue beat(16)9
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-0.59%
EPS NQ rev (3m)2.39%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 1.49
Fwd PE 1.33
P/S 0.21
P/FCF 1.95
P/OCF 1.4
P/B N/A
P/tB N/A
EV/EBITDA 6.62
EPS(TTM)5.22
EY67.18%
EPS(NY)5.86
Fwd EY75.37%
FCF(TTM)3.99
FCFY51.36%
OCF(TTM)5.54
OCFY71.36%
SpS36.92
BVpS-2.08
TBVpS-61.42
PEG (NY)0.29
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROCE 9.41%
ROIC 6.78%
ROICexc 7.21%
ROICexgc 32.42%
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
FCFM 10.81%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.45%
ROIC(5y)4.93%
ROICexc(3y)5.7%
ROICexc(5y)5.13%
ROICexgc(3y)40.1%
ROICexgc(5y)34.22%
ROCE(3y)7.57%
ROCE(5y)6.85%
ROICexgc growth 3Y34.27%
ROICexgc growth 5Y-5.74%
ROICexc growth 3Y14.02%
ROICexc growth 5Y12.75%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Debt/EBITDA 6.2
Cap/Depr 34.45%
Cap/Sales 4.21%
Interest Coverage 250
Cash Conversion 45.65%
Profit Quality 299.45%
Current Ratio 1.3
Quick Ratio 0.97
Altman-Z 0.24
F-Score7
WACC6.58%
ROIC/WACC1.03
Cap/Depr(3y)22.53%
Cap/Depr(5y)20.55%
Cap/Sales(3y)3.31%
Cap/Sales(5y)3.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%
EBIT growth 1Y18.58%
EBIT growth 3Y5.56%
EBIT growth 5Y6.8%
EBIT Next Year16.54%
EBIT Next 3Y4.34%
EBIT Next 5Y-1.3%
FCF growth 1Y21.39%
FCF growth 3Y3.22%
FCF growth 5Y0.55%
OCF growth 1Y34.83%
OCF growth 3Y3.85%
OCF growth 5Y1.25%

BAUSCH HEALTH COS INC / BHC.CA FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.CA.


Can you provide the valuation status for BAUSCH HEALTH COS INC?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC.CA). This can be considered as Undervalued.


Can you provide the profitability details for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC.CA) has a profitability rating of 6 / 10.


Can you provide the financial health for BHC stock?

The financial health rating of BAUSCH HEALTH COS INC (BHC.CA) is 3 / 10.